Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Table“
Suchtreffer
Begriffe & Kennungen
Akynzeo · 4.8 · 58 Table1: Adverse reactions System organ class Common Uncommon Rare Infections and Cystitis infestations Bloo
Eintrag öffnenAkynzeo · 4.8 · 7 Table1: Adverse reactions System organ class Common Uncommon Rare Infections and Cystitis infestations Blood
Eintrag öffnenAkynzeo · 4.8 · Netupitant No common adverse reactions are attributable to netupitant, the new component of the fixed combinat
Eintrag öffnenAkynzeo · 4.8 · Netupitant: No common adverse reactions are attributable to netupitant, the new component of the fixed combina
Eintrag öffnenAkynzeo · 4.8 · Netupitant: No common adverse reactions are attributable to netupitant, the new component of the fixed combina
Eintrag öffnenAkynzeo · 4.8 · Netupitant: No common adverse reactions are attributable to netupitant, the new component of the fixed combina
Eintrag öffnenAlecensa · 4.8 · Table 3 ADRs reported in Alecensa clinical trials (BO40336, BO28984, NP28761, NP28673; N = 533) System organ c
Eintrag öffnenAlecensa · 4.8 · Tabulated list of adverse drug reactions Table 3 lists the ADRs occurring in patients who received Alecensa ac
Eintrag öffnenAlecensa · 4.8 · The ADRs listed in Table 3 are presented by system organ class and frequency categories, defined using the fol
Eintrag öffnenAlimta · 4.8 · 8 Table 4. Frequencies of all grades adverse drug events regardless of causality from the pivotal registration
Eintrag öffnenAlimta · 4.8 · The table 4 lists the adverse drug events regardless of causality associated with pemetrexed used either as a
Eintrag öffnenAlprolix · 4.8 · Table 2 presented below is according to the MedDRA system organ classification (SOC and Preferred Term Level).
Eintrag öffnenAlprolix · 4.8 · Table 2: Adverse reactions reported for ALPROLIX MedDRA System Organ Class Adverse reactions Frequency categor
Eintrag öffnenAltuvoct · 4.8 · 7 Table 2: Adverse reactions reported for ALTUVOCT
Eintrag öffnenAltuvoct · 4.8 · Adverse drug reactions (ADRs) (summarized in Table 2) were reported in 111 (40.1%) of the 277 subjects treated
Eintrag öffnenAltuvoct · 4.8 · Table 2 presented below is according to the MedDRA system organ classification (SOC and Preferred Term Level).
Eintrag öffnenAmeluz · 4.8 · Table 1: Summary of related adverse drug reactions (ADRs) reported in patients treated with photodynamic thera
Eintrag öffnenAngina pectoris, instabile
Eintrag öffnenAngina pectoris, stabile
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.8 · The frequencies assigned to the adverse reactions identified in the table below include crude incidence rates
Eintrag öffnen